Guidance for industry : recommendations for obtaining a labeling claim for communicable disease donor screening tests using cadaveric blood speciments from donors of human cells, tissues and cellular and tissue-based products (HCT/Ps).
- 1 of 1 copy available at Evergreen Indiana.
0 current holds with 1 total copy.
View other formats and editions
|Location||Call Number / Copy Notes||Barcode||Shelving Location||Status||Due Date|
|Indiana State Library - Indianapolis||HE 20.4802:L 11 (Text)||991862-1001||Online document||Available||-|
- Physical Description: i, 7 pages : digital, PDF file
- Publisher: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 
Title from PDF title page (viewed on May 21, 2009).
|Bibliography, etc. Note:||
Includes bibliographical references (page 7).
|System Details Note:||
Mode of access: Internet at the FDA CBER web site. Address as of 5/21/09: http://www.fda.gov/cber/gdlns/cadbldhctp.pdf ; current access is available via PURL.
Search for related items by subject
|Subject:||Blood > Examination > United States.
Cell culture > United States > Testing.
Donation of organs, tissues, etc. > United States > Testing.
Communicable diseases > United States > Prevention.